---
category: news
title: "KidneyIntelX Enables Monitoring of SGLT2 Inhibitor Therapy Response and Corresponding Risk Reduction Over Time"
excerpt: "Renalytix plc (LSE: RENX) (NASDAQ: RNLX) announces new data demonstrating KidneyIntelX can be effective at monitoring therapeutic response and improvements in kidney health over time in adults with type 2 diabetes."
publishedDateTime: 2021-06-28T11:00:00Z
originalUrl: "https://www.wallstreet-online.de/nachricht/14089480-kidneyintelx-enables-monitoring-of-sglt2-inhibitor-therapy-response-and-corresponding-risk-reduction-over-time/all"
webUrl: "https://www.wallstreet-online.de/nachricht/14089480-kidneyintelx-enables-monitoring-of-sglt2-inhibitor-therapy-response-and-corresponding-risk-reduction-over-time/all"
type: article

provider:
  name: wallstreet online
  domain: wallstreet-online.de

topics:
  - AI in Healthcare
  - AI

secured: "aI0/W85h1aIwVQIbGvghlLiYBjc0huABtCI1txzLWO6GF2jngRwRkBF/g874vfkHbqrUv0Y95MV9C2Zw0QIEw9AOhPDUSDVXvgQdAnSnMQc+83ADNnE1bbh6QBMd6Smp3Kc8AYlPCchnynKCNEdhURWKt1Uu/jLUC31q3YuV3uaqisE1PvET1LzFPSn3WxJP1LQrO+PaKjaoqrtvJEZG52UOT5I5yA+QMo/XplEhPZXE8uP/v4Id41RnMsjmnO7IRXMX3ObvNEfbIIexz+smLLZL+vNPFluR871+s4BjpKOzk3Aefb7V7axuQz/cC1n+iL2MEg654bimLjPH/eTXjBAMjaqRTr9/6lKLlfsY90A=;uixJClWaZB2r2TI27MK1bQ=="
---

